Skip to main content
Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
0.9431
+0.1007 (11.95%)
Nov 13, 2026, 4:00 PM EST - Market closed

Perspective Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
Net Income
-122.91-103.12-79.28-46.51-10.76-7.27
Depreciation & Amortization
4.463.242.30.710.320.28
Other Amortization
0.010.010.010.0100.01
Loss (Gain) From Sale of Assets
--0.030.020.31-
Asset Writedown & Restructuring Costs
--24.06---
Loss (Gain) From Sale of Investments
-2.16-2.72-0.61---
Stock-Based Compensation
11.048.975.223.140.981.09
Other Operating Activities
9.449.46-2.06-2.24-0.220
Change in Accounts Receivable
0.170.111.050.20.280.41
Change in Inventory
-----2-2.67
Change in Accounts Payable
-9.130.151.891.570.690.24
Change in Unearned Revenue
--1.428---
Change in Other Net Operating Assets
0.962.820.860.79-0.030.18
Operating Cash Flow
-108.13-82.48-18.29-36.91-10.4-7.71
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
Capital Expenditures
-30.66-12.75-54.41-1.07-0.28-0.27
Sale of Property, Plant & Equipment
--0.34---
Cash Acquisitions
---2.7--
Investment in Securities
-11.5154.11-164.7822.76-22.69-
Other Investing Activities
-0.09-0.14-0.07-0.02-6.02-0.02
Investing Cash Flow
-42.2741.23-218.9324.37-28.99-0.28

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
Long-Term Debt Repaid
--0.05-0.05-0.07--
Net Debt Issued (Repaid)
-0.06-0.05-0.05-0.07--
Issuance of Common Stock
164.7310.36289.430.920.030.06
Other Financing Activities
----0.07--
Financing Cash Flow
164.6710.31289.390.790.030.06

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
Net Cash Flow
14.28-30.9552.16-11.76-39.36-7.94

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
Free Cash Flow
-138.79-95.23-72.71-37.99-10.68-7.98
Free Cash Flow Growth
------
Free Cash Flow Margin
-63086.36%-10772.96%-5000.55%-2648.88%-197.28%-
Free Cash Flow Per Share
-1.32-1.29-1.13-1.42-0.75-0.56
Levered Free Cash Flow
-78.37-60.37-83.66-8.54--2.73
Unlevered Free Cash Flow
-78.13-60.14-83.63-8.49--2.73

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
Change in Working Capital
-8.011.6831.82.56-1.05-1.85
SEC Filings: 10-K · 10-Q